Cancer
-
April 17, 2013 | Research News
UGA research finds sterilized dogs live longer
Many dog owners have their pets spayed or neutered to help control the pet population, but new research from the University of Georgia suggests the procedure could add to the length of their lives and alter the risk of specific causes of death.
-
February 1, 2013 | Research News
New drug targets found for treatment of prostate cancer
Prostate cancer cells need certain enzymes to grow tumors, and an often overlooked enzyme-Pak1-is key for their growth, according to new research from the University of Georgia.
-
January 11, 2013 | Research News
UGA discovery promises to improve drugs used to fight cancer, other diseases
Even when at rest, the human body is a flurry of activity. Like a microscopic metropolis locked in a state of perpetual rush hour traffic, the trillions of cells that make us who we are work feverishly policing the streets, making repairs, building new structures and delivering important cargo throughout the bustling organic society.
-
November 1, 2012 | Research News
Detecting silent killers: UGA researchers receive $4.1 million to diagnose elusive cancers
Ovarian and pancreatic cancers are among the most deadly, not because they are impossible to cure, but because they are difficult to find. There are no screening tests that can reliably detect their presence in early stages, and most diagnoses are made after the disease has already spread to lymph nodes and vital organs.
-
October 31, 2012 | Research News
UGA researchers discover how tiny sugars regulate stem cells
Embryonic stem cells hold great promise as a potential cell-based therapy for a myriad of serious diseases, but there is still much to learn before they become a regular part of the doctor's toolkit. Scientists do not yet fully understand the complex processes that take place during the earliest stages of development when stem cells in the embryo begin to transform into specialized cells that can be used to regenerate bones, tissues and nerves.
-
May 3, 2012 | Research News
Study suggests new approach to explain cancer growth: low oxygen levels
Low oxygen levels in cells may be a primary cause of uncontrollable tumor growth in some cancers, according to a new University of Georgia study. The authors' findings run counter to widely accepted beliefs that genetic mutations are responsible for cancer growth.
-
March 27, 2012 | Research News
Researchers use nanoparticles, magnetic current to damage cancerous cells in mice
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
-
March 13, 2012 | Research News
UGA College of Public Health cancer survival study uncovers wide racial disparities
African Americans in Georgia, especially in rural areas, have drastically poorer survival rates from cancer. These disparities are much larger when compared to national data, according to the findings from a study recently published in the journal Cancer by a team of researchers in the University of Georgia College of Public Health.
-
February 27, 2012 | Honors & Awards
UGA researcher working to speed blood testing
The wait for some blood test results may be reduced from weeks to hours, thanks to research being conducted at the University of Georgia. Leidong Mao, an assistant professor with the UGA Faculty of Engineering, is refining a device to manipulate blood cells and other particles that shows promise in detecting and treating blood diseases. He has recently received a National Science Foundation CAREER Award to further his work.
-
February 9, 2012 | General News
UGA nutrition experts available
Proper nutrition is essential for the body to function. A nutritious diet provides the nutrients needed for a lifetime of health and aids in the prevention of chronic disease, obesity and cancer.
-
December 12, 2011 | Research News
Scientists develop vaccine that attacks breast cancer in mice
Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those resistant to common treatments.
-
November 30, 2011 | Research News
UGA pharmacy researcher continues work on melanoma treatment
A research scientist in the University of Georgia College of Pharmacy is continuing her work on melanoma, a type of skin cancer that has become an emerging health crisis in the United States, with a grant from the American Cancer Society.
-
November 2, 2011 | General News
UGA experts available to speak on medication shortages
From chemotherapy drugs to electrolyte treatments to antibiotics, key medications are in short supply in pharmacies across the nation. At the University of Georgia College of Pharmacy, the faculty is well aware of the issues—and the burdens these shortages place on pharmacists, physicians and patients.
-
October 18, 2011 | Research News
UGA scientists team up to define first-ever sequence of biologically important carbohydrate
Scientists have been unable to determine the structure of a biologically important so-called GAG proteoglycan-or even to agree whether these remarkably complex molecules have well-defined structures.In a paper published in the early online edition of the journal Nature Chemical Biology, however, a team of scientists from the University of Georgia and Rensselaer Polytechnic Institute announced that it has, for the first time, determined the sequence and structure of a glycosaminoglycan, or GAG, proteoglycan.
-
October 4, 2011 | Events on Campus
‘Ecology of War’ focus of upcoming Willson Center lecture
Pulling from his research into unexploded ordnance and their carcinogenic effects on the island of Vieques, Puerto Rico, University of Georgia ecologist James W. Porter will present "The Ecology of War" Oct. 12 at 4 p.m. in room 248 of the Miller Learning Center. His talk is part of the UGA Willson Center for Humanities and Arts Science for Humanists lecture series, which is free and open to the public.